Telmisartan attenuated LPS-induced neuroinflammation in human IMR-32 neuronal cell line via SARM in AT1R independent mechanism

Life Sciences

Volumn 130, Issue , 2015, Pages 88-96

  Saravanan, Prathab Balaji ^a   Shanmuganathan, Muthusamy V ^b   Ramanathan, Muthiah ^a  

^a PSG COLLEGE OF PHARMACY   (India)

^b NATIONAL INSTITUTE OF NUTRITION   (India)

Author keywords

Cytokines; ERK; IMR 32 cell line; JNK; LPS; MAPK; MyD88; p65(NF B); PPAR ; SARM

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; NEUROPROTECTIVE AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOPROTEIN; REGULATOR PROTEIN; STERILE ALPHA AND ARMADILLO MOTIF CONTAINING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TELMISARTAN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 2-CHLORO-5-NITROBENZANILIDE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANILIDE; ARMADILLO DOMAIN PROTEIN; AUTACOID; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; CYTOKINE; CYTOSKELETON PROTEIN; LIPOPOLYSACCHARIDE; SARM1 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MOUSE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL LINE; DRUG EFFECTS; INFLAMMATION; METABOLISM; NERVE CELL; PATHOLOGY;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANILIDES; ARMADILLO DOMAIN PROTEINS; BENZIMIDAZOLES; BENZOATES; CELL LINE; CYTOKINES; CYTOSKELETAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTOR, ANGIOTENSIN, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 4;

EID: 84928411674     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.03.005     Document Type: Article

References (43)

1. A.M. Garrido, and K.K. Griendling NADPH oxidases and angiotensin II receptor signaling Mol. Cell. Endocrinol. 302 2009 148 158
2. Amano Y, Yamaguchi T, Ohno K, Niimi T, Orita M, Sakashita H, Takeuchi M, Structural basis for telmisartan mediated partial activation of PPAR gamma, Hypertens. Res. 2012; 35:715-719.
3. S.C. Benson, H.A. Pershadsingh, C.I. Ho, A. Chittiboyina, P. Desai, and M. Pravenec Identification of Telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity Hypertension 43 2004 993 1002
4. T. Bondeva, T. Roger, and G. Wolf Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites Am. J. Nephrol. 27 2007 308 314
5. Carty M, Goodbody R, Schröder M, Stack J, Moynagh PN, Bowie AG, The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signalling, Nat. Immunol. 2006; 7:1074-1081
6. P.N. Cunningham, Y. Wang, R. Guo, G. He, and R.J. Quigg Role of Toll-like receptor 4 in endotoxin-induced acute renal failure J. Immunol. 172 2004 2629 2635
7. M.R. Dasu, A.C. Riosvelasco, and I. Jialal Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo Atherosclerosis 202 2009 76 83
8. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, Staels B, Peroxisome proliferator-activated receptor a negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kB and AP-1, J. Biol. Chem. 1999; 274:32048-54.
9. D.V. Erbe, K. Gartrell, Y.L. Zhang, V. Suri, S.J. Kirincich, and S. Will Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists Vasc. Pharmacol. 45 2006 154 162
10. P. Garrido-Gil, B. Joglar, A.I. Rodriguez-Perez, M.J. Guerra, and J.L. Labandeira-Garcia Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist Telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease J. Neuroinflammation 9 2012 38
11. M. Guha, and N. Mackman LPS induction of gene expression in human monocytes Cell. Signal. 13 2001 85 94
12. Iyer SS, Ghaffari AA, Cheng G, Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages, J. Immunol. 2010; 185:6599-607
13. Y. Ji, J. Liu, Z. Wang, N. Liu, and W. Gou PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway Lab. Investig. 89 2009 887 902
14. Ji YY, Liu JT, Liu N, Wang ZD, Liu CH, PPAR alpha activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4 dependent signalling pathway, Biochem. Pharmacol. 2009a; 78:1186-97
15. T. Kaisho, and S. Akira Toll-like receptor function and signaling J. Allergy Clin. Immunol. 117 2006 979 987
16. T. Kawai, O. Adachi, T. Ogawa, K. Takeda, and S. Akira Unresponsiveness of MyD88-deficient mice to endotoxin Immunity 11 1999 115 122
17. Y. Kong, and Y. Le Toll-like receptors in inflammation of the central nervous system Int. Immunopharmacol. 11 2011 1407 1414
18. Krishnan S, Shanmuganathan MV, Behenna D, Stoltz BM, Prasadarao NV, Angiotensin II receptor type 1 - a novel target for preventing neonatal meningitis in mice by Escherichia coli K1, J. Infect. Dis. 2014;209(3):409-19 (1).
19. Z.J. Liu, W. Liu, L. Liu, C. Xiao, Y. Wang, and J.S. Jiao Curcumin protects neuron against cerebral ischemia-induced inflammation through improving PPAR-gamma function Evid. Based Complement. Alternat. Med. 470975 2013
20. A. Lombardi, G. Cantini, E. Piscitelli, S. Gelmini, M. Francalanci, and T. Mello A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-α and interferon-γ inflammatory effects in human endothelial cells Arterioscler. Thromb. Vasc. Biol. 28 2008 718 724
21. Y. Lu, and L.M. Wahl Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-kappa B activity in lipopolysaccharide-activated human primary monocytes J. Immunol. 175 2005 5423 5429
22. Y.C. Lu, W.C. Yeh, and P.S. Ohashi LPS/TLR4 signal transduction pathway Cytokine 42 2008 145 151
23. J. Lv, R. Jia, D. Yang, J. Zhu, and G. Ding Candesartan attenuates angiotensin II-induced mesangial cell apoptosis via TLR4/MyD88 pathway Biochem. Biophys. Res. Commun. 380 2009 81 86
24. Martin H, Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components. Mutat. Res. 2010; 690:57-63
25. M. Mogi, J. Iwanami, and M. Horiuchi Roles of brain angiotensin II in cognitive function and dementia Int. J. Hypertens. 169649 2012
26. Mion F, Tonon S, Toffoletto B, Cesselli D, Puccillo CE, Vitale G, IL-10 production by B cells is differentially regulated by immune mediated and infectious stimuli and requires p38 activation, Mol. Immunol. 2014; 62: 266-76
27. T. Pang, J. Benicky, J. Wang, M. Orecna, E. Sanchez-Lemus, and J.M. Saavedra Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes J. Hypertens. 30 2012 87 96
28. T. Pang, J. Wang, J. Benicky, E. Sánchez-Lemus, and J.M. Saavedra Telmisartan directly ameliorates the neuronal inflammatory response to IL-1β partly through the JNK/c-Jun and NADPH oxidase pathways J. Neuroinflammation 9 2012 102
29. J. Peng, Q. Yuan, B. Lin, P. Panneerselvam, X. Wang, X.L. Luan, S.K. Lim, B.P. Leung, B. Ho, and J.L. Ding SARM inhibits both TRIF and MyD88 mediated AP-1 activation Eur. J. Immunol. 40 2010 1738 1747
30. M.E. Pueyo, W. Gonzalez, A. Nicoletti, F. Savoie, J.F. Arnal, and J.B. Michel Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress Arterioscler. Thromb. Vasc. Biol. 20 2000 645 651
31. J. Rodriguez-Pallares, J.A. Parga, B. Joglar, M.J. Guerra, and J.L. Labandeira-Garcia Mitochondrial ATP-sensitive potassium channels enhance angiotensin- induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson's disease Age 34 2012 863 880
32. Romics L Jr, Kodys K, Dolganiuc A, Graham L, Velayudham A, Mandrekar P, Szabo G, Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver, Hepatology 2004; 40:376-85.
33. N. Rotman, and W. Wahli PPAR modulation of kinase-linked receptor signaling in physiology and disease Physiology (Bethesda) 25 2010 176 185
34. Shindo T, Takasaki K, Uchida K, Onimura R, Kubota K, Uchida N, Irie K, Katsurabayashi S, Mishima K, Nishimura R, Fujiwara M, Iwasaki K, Ameliorative effects of Telmisartan on the inflammatory response and impaired spatial memory in a rat model of Alzheimer's disease incorporating additional cerebrovascular disease factors, Biol. Pharm. Bull. 2012; 35:2141-7
35. Szretter KJ, Samuel MA, Gilfillan S, Fuchs A, Colonna M, Diamond MS, The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesis, J. Virol. 2009; 83:9329-38.
36. O. Takeuchi, K. Takeda, K. Hoshino, O. Adachi, T. Ogawa, and S. Akira Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades Int. Immunol. 12 2000 113 117
37. D.M. Tham, B. Martin-McNulty, Y.X. Wang, D.W. Wilson, R. Vergona, and M.E. Sullivan Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs Physiol. Genomics 11 2002 21 30
38. Wang HM, Zhao YX, Zhang S, Liu GD, Kang WY, Tang HD, Ding JQ, Chen SD, PPAR gamma agonist curcumin reduces the amyloid-beta-stimulated inflammatory responses in primary astrocytes, J. Alzheimers Dis. 2010; 20:1189-99
39. Wang J, Pang T, Hafko R, Benicky J, Sanchez-Lemus E, Saavedra JM, Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT1 receptor blockade and PPARγ activation, Neuropharmacology 2014; 79:249-61
40. Wang N, Verna L, Chen NG, Chen J, Li H, Forman BM, Stemerman MB, Constitutive activation of peroxisome proliferator activated receptor gamma suppresses pro inflammatory adhesion molecules in human vascular endothelial cells, J. Biol. Chem. 2002; 277:34176-81
41. H. Wu, G. Chen, K.R. Wyburn, J. Yin, P. Bertolino, J.M. Eris, S.I. Alexander, A.F. Sharland, and S.J. Chadban TLR4 activation mediates kidney ischemia/reperfusion injury J. Clin. Invest. 117 2007 2847 2859
42. S.M. Zhao, L.H. Shen, H.W. Li, L. Wang, H. Chen, Y.L. Wang, and C.Y. Guo Down-regulation of the expression of angiotensin II type 1 receptor in neonatal rat cardiac fibroblast by activation of PPARgamma signal pathway Chin. J. Phys. 51 2008 357 362
43. Zotova E, Bharambe V, Cheaveau M, Morgan W, Holmes C, Harris S, Neal JW, Love S, Nicoll JA, Boche D, Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization, Brain 2013; 136:2677-96